Susceptibility ‐guided sequential strategy versus empirical therapy for Helicobacter pylori infection: study protocol for a randomised controlled trial
DiscussionThis randomised controlled trial will provide objective and valid evidence about the value of polymerase chain reaction-based molecular methods for antibiotic susceptibility testing in guidingH. pylori eradication.Trial registrationClinicaltrials.gov NCT05549115. Released on 18 September 2022. First posted on 22 September 2022. Enrolment of the first participant on 20 September 2022. The study is retrospectively registered. (Source: Trials)
Source: Trials - June 19, 2023 Category: Research Source Type: clinical trials
Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
Condition: Helicobacter Pylori Infection Interventions: Drug: Esomeprazole; Drug: Lansoprazole; Drug: Amoxicillin; Drug: Clarithromycin Sponsor: Finni Kollins Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2023 Category: Research Source Type: clinical trials
The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)
Condition: Drug Drug Interaction Interventions: Drug: Givinostat; Drug: Clarithromycin Sponsor: Italfarmaco Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
